glp-1 trials Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Clinical trials suggest GLP-1s may

Patients with pre-existing balance problems may find symptoms more troublesome

Omada's Chief Medical Officer Carolyn Bradner Jasik, MD provides an overview of GLP-1 medications and their history in the first part of a video blog series discussing Omada's clinical stance on GLP-1s.

Cushing syndrome , whether from excess cortisol production or chronic steroid use, causes characteristic central weight gain

These drugs not only provide unprecedented efficacy and acceptable safety in weight reduction and glycemic control for patients with obesity and Type 2 diabetes but also hold promise in broader indications, including neurodegenerative disorders, fatty liver disease, dyslipidemia, atherosclerosis, and cardiovascular conditions

The issue is effectiveness